PROGRAM

View Program Timetable

Keynote Speakers

Professor Jacques BERNIER - Head of EORTC ( Radiation Oncologist), Oncology Institute of Southern Switzerland

Professor Robert ORD - Professor of Dentistry, Head, Division of Oral-Maxillofacial Surgery, University of Maryland Medicine

Professor Stephen PORTER - Head of Unit, Oral Medicine and Special Needs Dentistry, Eastman Dental Institute, Professor of Oral Medicine, University of London

Professor Randal S WEBER - Editor of Head & Neck Journal, Director of Head Neck Surgery, University of Pennsylvania, USA

Professor Jacques R F Bernier MD, PD

Chairman, Department of Radio-Oncology and Nuclear Medicine, Oncology Institute of Southern Switzerland

Privat Docent at the University of Geneva, Switzerland

Chairman, Head and Neck Cooperative Group of the EORTC

Chairman, European InterGroup for Head and Neck Cancer Radiotherapy

Professor Robert Ord

Professor Robert Ord

Professor of Dentistry, Head, Division of Oral-Maxillofacial Surgery, University of Maryland Medicine

Born in Cardiff, Wales, UK. Trained in Dentistry at Kings College Hospital London, England 1966 - 1970 trained in Medicine, Cardiff 1972 - 1977. Dr. Ord is a Fellow of the Royal College of Surgeon of Edinburg, a Fellow of the American College of Surgeons and has an MS in Oral Pathology from the University of Maryland. Dr. Ord came to the University of Maryland in 1989.

Dr. Ord is the Chief of Division of Oral and Maxillofacial Surgery at the University of Maryland Medical Systems and an Associate professor at the Greenebaum Cancer Center.

Clinical Interests
My main interest is in surgical oncology of the head and neck, that is, management of tumors of the head and neck. Most of my surgeries are related to cancer of the oral cavity, jaws, sinuses and salivary glands. In addition I have an interest in benign tumors of this region and reconstruction of the jaws and oral cavity.

Research Interests
I have an ongoing interest in basic science and clinical research in head and neck malignancy. I am also active in chemoprevention trials for premalignant lesions.

Teaching
I have a heavy commitment to graduate teaching at the residency and Fellowship level. In addition, I lecture widely at National and International Meetings. I am an Examiner for the American Board of Oral and Maxillofacial Surgery, the Royal College of Surgeons of Edinburg, and the University of Singapore.

Publications
I have published over 70 Scientific papers, 15 plus book chapters and I am currently finishing a book on "Oral Cancer". I am on the Editorial Board of the European Journal of Craniomaxillofacial Surgery and the International Journal of Oral and Maxillofacial Surgery.

Professor Stephen Porter, PhD, MD, FDS RCS, FDS RCSE

Head of Unit, Oral Medicine and Special Needs Dentistry, Eastman Dental Institute, Professor of Oral Medicine University of London

Stephen Porter qualified in Biochemistry (1979) and Dentistry (1982) at the University of Glasgow. He subsequently gained his Doctor of Philosophy (1987), Bachelor of Medicine and Bachelor of Surgery (1991) and Doctor of Medicine (1993) at the University of Bristol, and Fellowships in Dental Surgery of the Royal Colleges of Surgeons of Edinburgh (1987) and England (1987). He was Lecturer in Oral Medicine in the University of Bristol (1991-3) before coming to The Eastman as Senior Lecturer in Oral Medicine.

Professor Porter is currently Head of the Oral Medicine Unit. He is Honorary Consultant at University College London Hospitals.

Clinical Expertise
Professor Porter's clinical expertise is mainly Oral Medicine, especially ulceration, dysplastic lesions and oral aspects of dermatological and rheumatological disease.

Research Interests
His main research interests are in virology and immunology in relation to oral disease, in particular the oral and dental aspects of Hepatitis C virus, aetiological considerations of Human Herpesvirus 8 and the aetiology and management of oral lichen planus.

Professor Randal S Weber, M.D., F.A.C.S.

Gabriel Tucker Professor and Vice-Chair

Department of Otorhinolaryngology: Head and Neck Surgery

Director, Center for Head & Neck Cancer, University of Pennsylvania Health System

Fellowship: Area of Concentration
Tumors of the thyroid, parathyroid and salivary gland, skull base tumors, head and neck cancer

Areas of Expertise
Tumors of the thyroid, parathyroid and salivary gland
Skull base tumors
Head and neck cancer

Areas of Special Interest
Thyroid
Parathyroid
Skin cancer
Salivary gland tumors

Current Research Interests
Organ preservation for oropharyngeal cancer
Nerve invasion in head and neck cancer

Monday 17 November

Opening Address:
Peter C. Doherty, AC, FAA, FRS
Laureate Professor
Department of Microbiology and Immunology
University of Melbourne

Program Outline

Program Theme: Evidence Based Practice in the Management of Head and Neck Cancer

Information

The information age, patient knowledge, patient care and informed consent;

Medico-legal issues;

Web-based international data and the informational needs of patients.

The Jaw

Bone invasion - pathology, incidence and significance;

Jaw resection - marginal or segmental, indications, techniques, outcomes;

Jaw reconstruction - which options, when and why;

Osseointegration and prosthetics - indications, techniques, functional results, pitfalls;

Osteoradionecrosis - prevention, causes, treatment.

Clinical Trials

Trials that have been done and those still waiting to be done;

From the viewpoint of a radiation oncologist, a head and neck surgeon, an oral and maxillofacial surgeon and an oral medicine specialist.

Imaging of the Jaw

When and why to order a MRI scan in the management of head and neck cancer;

Positron emission tomography in head and neck cancer;

Functional computer tomography in head and neck cancer.

The Oral Cavity

Oral cancers - verrucous cancers;

Local, regional and free flaps;

Complex defects - jaw and soft tissue, full thickness defects, flap failure.

Healing

What to do when your patient doesn't heal;

Pain control - all you need to know in 15 minutes;

The do's and don'ts of patient communication;

Patient transition from active to palliative care.

The Neck

The node positive neck - evaluation, selective or comprehensive surgery, adjuvant radiotherapy, outcomes;

The node negative neck - evaluation by computer tomography and ultrasound guided fine needle aspirate, elective nodal treatment;

Sentinel node biopsy - technique, indications, pitfalls;

Radiotherapy - the N2/3 neck and planned neck dissection.

Translational Research

Translational research;

Molecular biology;

Molecular analysis of metastases.

Functional Outcomes and Quality of Life

Functional outcomes - what, how and why;

Objective assessment of swallowing function;

Measurements and analyses of quality of life for head and neck cancer patients.

Social Program

WELCOME RECEPTION - Monday 17 November 2003
The Terrace - Hotel Sofitel
6.00pm - 7.30pm
Inclusive for registered delegates (Full, ANZHNS, Concessional and Trainee rates) and accompanying persons.

CONGRESS DINNER - Tuesday 18 November 2003
Zinc @ Federation Square
7.00pm - 11.00pm
Inclusive for registered delegates (Full, ANZHNS, Concessional and Trainee rates) and accompanying persons.